Product News
Metrohm Expands Raman Chemical Warfare Agent Library
A recent update to the Raman Chemical Warfare Agents (CWA) library increases the number of compounds that can be identified to 111 deadly substances.
Product News
DNAnexus and Galatea Bio Launch Collaboration To Enhance Precision Medicine With Advanced Genetic Tools for Underserved Populations
DNAnexus, Inc., provider of the Precision Health Data Cloud, and Galatea Bio, committed to 'Precision Health at Scale for All,' announced a strategic collaboration to enhance biomedical research and precision medicine.
Product News
FDA Approves AChEI ALPHA-1062 for Alzheimer’s Disease Treatment
On July 29, 2024, the U.S. FDA approved Alpha Cognition Inc.'s ALPHA-1062 (Zunveyl®), an Acetylcholinesterase (AChE) inhibitor, for treating mild-to-moderate Alzheimer’s disease.
Product News
FDA Accepted PD-L1 Inhibitor Durvalumab for the Treatment of Endometrial Cancer
On June 14, 2024, the U.S. FDA approved AstraZeneca's Durvalumab (IMFINZI®) for primary advanced or recurrent endometrial cancer with mismatch repair deficiency.
Product News
CellProthera Begins Long-Term Observational Study To Demonstrate Safety and Efficacy of ProtheraCytes® Cell Therapy in Acute Myocardial Infarction
The long-term PERFECT observational study follows patients from successful Phase I/IIb of ProtheraCytes for the repair and regeneration of damaged cardiac tissues after severe heart attack.
Product News
Bio-Rad’s Study Demonstrating Utility of Its SpyLock Technology for Fast Generation and Screening of Bispecific Antibodies
Study describes method to successfully modify the functional activity of Spycatcher protein for the rapid generation and high-throughput screening of bispecific antibodies.
Advertisement
